Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial

Use Case
Accelerating Diversity Enrollment in a Phase III COVID-19 Trial

Citeline Connect Helps Sponsor Reach Diversity & Inclusion Goals

With the eyes of the world upon on them, a biotechnology company’s COVID-19 Phase III clinical trial inched closer to its target enrollment of 30,000 participants but was not meeting one milestone: inclusion of participants from communities that...Contents

A Recruiting Challenge for One of the Most Pivotal Clinical Trials of Our Lifetime

Citeline Connect
to the Rescue

Setting Up Sites
for Success

Randomizations
Over Time

Citeline Connect Delivers 20% of Randomizations

Recruitment Funnel (Sept. 17 – Oct. 19)

Recruitment Partner Perspective

Connect. Refer.
Screen. Enroll

Thank you for reading

Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial